Insero Health Takes Aim at Epilepsy with Huperzine
By Marie Powers
Monday, February 27, 2012
One of the oldest conditions known to humans, epilepsy continues to confound drug developers, with nearly one in three patients refractory on one or more antiepileptic drugs.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.